LINDSEY HOFSTRAND: Open Payments
NPI 1710665260 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 18 payments from 7 companies in 2025. Trend: 2023 $418 · 2024 $425 · 2025 $1,031
Food & beverage: $833Education: $198
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 7 | $299 |
| United Therapeutics Corporation | 5 | $200 |
| AstraZeneca Pharmaceuticals LP | 2 | $156 |
| Verona Pharma, Inc. | 1 | $124 |
| Regeneron Healthcare Solutions, Inc. | 1 | $111 |
| GlaxoSmithKline, LLC. | 1 | $98 |
| HARMONY BIOSCIENCES LLC | 1 | $44 |
Products named: OPSUMIT, Ohtuvayre, DUPIXENT, FASENRA, NUCALA, UPTRAVI, TEZSPIRE, WAKIX.
Industry payments across PA — which companies pay providers there.
